The bill amends Section 18 of P.L.2021, c.16 (C.24:6I-35) to require cannabis retailers to display a notice at the point of sale that informs customers about the potential health risks associated with high potency cannabis. This notice must specifically address the health risks for individuals under 25 years of age and those who have or are at risk for developing mental health conditions or psychotic disorders. Additionally, it will provide resources for individuals seeking assistance in reducing or ceasing cannabis consumption. The Cannabis Regulatory Commission (CRC) is responsible for developing the content of this notice to ensure it effectively communicates the necessary health information.

Furthermore, the bill includes provisions to regulate the advertising and marketing of cannabis products, ensuring they do not appeal to individuals under the legal purchasing age. It establishes strict guidelines for advertising, including age verification requirements for audiences, restrictions on event sponsorship, and mandates for warning labels on advertisements. The bill is set to take effect on the first day of the ninth month following its enactment, although the CRC is allowed to take necessary administrative actions in advance of this date.

Statutes affected:
Introduced: 24:6I-35